A Study to Learn More About the Menopausal Hormone Therapies in Korea
Treatment Patterns of Menopausal Hormone Therapy in South Korea: a Nationwide Cohort Study
Sponsor: Pfizer
Listed as NCT06033521, this observational or N/A phase trial focuses on Bone Demineralization and Menopause and remains completed. Sponsored by Pfizer, it has been updated 7 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
May 2025 — Sep 2025 [monthly]
Completed
-
Sep 2024 — May 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting
▶ Show 2 earlier versions
-
Dec 2023 — Apr 2024 [monthly]
Active Not Recruiting
Status: Not Yet Recruiting → Active Not Recruiting
-
Oct 2023 — Dec 2023 [monthly]
Not Yet Recruiting
First recorded
Sep 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pfizer
For direct contact, visit the study record on ClinicalTrials.gov .